Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism
Tonge, S.R.; Leonard, B.E.
Archives Internationales de Pharmacodynamie et de Therapie 195(1): 168-176
1972
ISSN/ISBN: 0003-9780 PMID: 5010826 Document Number: 45594
Document emailed within 1 workday
Related Documents
Shibanoki, S.; Kubo, T.; Ishikawa, K. 1987: Comparative study of phenothiazine derivatives on monoamine metabolism--direct correlation between the concentrations of drugs and monoamine metabolites in the brain Journal of Pharmacology and Experimental Therapeutics 240(3): 959-965Haan, J. 1981: Drug dependence. a review of the narcotic and hallucinogenic effects of drugs Medizinische Monatsschrift für Pharmazeuten 4(5): 129-137
Davydova, A.I.; Klodt, P.M.; Kudrin, V.S.; Kuznetsova, E.A.; Narkevich, V.B. 2010: Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015 Eksperimental'naia i Klinicheskaia Farmakologiia 73(3): 2-6
Pill, J.; Stegmeier, K.; Schmidt, F.H. 1990: Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis Methods and Findings in Experimental and Clinical Pharmacology 12(3): 167-174
Trulson, M.E.; Preussler, D.W.; Trulson, V.M. 1984: Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats Journal of Pharmacology and Experimental Therapeutics 228(1): 94-102
Ahmed, T. 1998: Drugs Affecting Lipid Metabolism--XIII International Symposium. 30 May-3 June 1998, Florence, Italy IDrugs: the investigational drugs journal 1(3): 281-285
Namba, M.; Yamamoto, S.; Tanaka, H.; Kanamori, T.; Nobuhara, M.; Kimoto, T. 1983: Potentiation of the cytotoxic effects of various anticancer drugs by interferon on human neoplastic cells (HeLa) in culture Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(5): 1308-1312
Logan, W.J. 1975: Neurological aspects of hallucinogenic drugs Advances in Neurology 13: 47-78
Bellman, S.W.; Turczan, J.W.; Kram, T.C. 1970: Spectrometric forensic chemistry of hallucinogenic drugs Journal of Forensic Sciences 15(2): 261-286
Mèszàros, J. 1983: Adverse effects of drugs: mechanisms and factors affecting their occurrence Polski Tygodnik Lekarski 38(51-52): 1615-1620
Ninnemann, A.; Stuart, G.L. 2013: The NBOMe series: a novel, dangerous group of hallucinogenic drugs Journal of studies on alcohol and drugs 74(6): 977-978
Fukuda, T.; Tsumagari, T. 1984: Effects of psychotropic drugs on lateral hypothalamic self-stimulation behavior in rats: correlation between self-stimulation behavior inhibition and striatal dopaminergic blockade by neuroleptic drugs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 83(6): 485-496
Finberg, J.P.; Youdim, M.B. 1988: Potentiation of tyramine pressor responses in conscious rats by reversible inhibitors of monoamine oxidase Journal of Neural Transmission. Supplementum 26: 11-16
Marek, J. 1985: On the non-specific antiinflammatory effects of other-than-antirheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs International Journal of Tissue Reactions 7(6): 475-504
Motta, G.; Ratto, G.B. 1980: Clinical observations on the rheological and hemodynamic effects of some drugs acting on the microcirculation Minerva Medica 71(19): 1367-1376
Naqvi, S.M.; Hasan, M. 1991: Regional alterations in the monoamine levels, monoamine oxidase activity and neurobehavioural effects in rats treated with Dimecron (phosphamidon) Indian Journal of Medical Research 94: 71-75
Vogel, H.C.; Wichmann, J.; Roseburg, B.; Fikentscher, R. 1974: Isolated taste disorders as side-effects of drugs: observations on D-penicillamine and D,L-oxyfedrine Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 29(11): 452-454
Zharkovskiĭ, A.M.; Allikmets, L.K. 1976: Effect of cholinergic drugs on serotonin metabolism and emotional reactions in rats Farmakologiia i Toksikologiia 39(3): 261-264
Omelka, M. 1997: Unauthorized manufacture and possession of hallucinogenic and psychotropic drugs and poisons. Present laws and possible de lege ferende solutions Casopis Lekaru Ceskych 136(21): 674-677
Villette, B.; Rybojad, M.; Puissant, A. 1989: Dermatologic manifestation of undesirable effects of drugs (excluding cytostatic drugs) Annales de Medecine Interne 140(7): 609-613